ALFA FinderNSE filing, NSE: PARKHOSPS. Summary written from the filing by ALFA Finder's alert engine.
Park Medi World Ltd: key numbers
- Share price
- ₹251.39
- Market cap
- ₹10,858 Cr
- Revenue (annual)
- ₹1,679 Cr
- Net profit (annual)
- ₹258.1 Cr
- P/E (TTM)
- 39.1×Sector 53.9×
- Promoter holding
- 82.90%+0.01% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Park Medi World Ltd
All →Park Medi World Management Change
Park Medi World appointed Abhishek Kumar as Head Accounts and designated him Senior Management Personnel. Sanjeev Taneja ceased to be SMP, both effective November 6, 2026.
Park Medi World Board Meeting Date
Park Medi World scheduled its Board Meeting for 09 Nov 2026 to consider Q1/H1 FY27 financial results. Trading window remains closed until 11 Nov 2026.
Park Medi World ED Probe / Tax Survey
Park Medi World disclosed an Income Tax Department verification at its and subsidiaries' premises from October 12-17, 2026. No violations alleged or operational impact reported.
Park Medi World Other Announcement
Park Medi World Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, pursuant to SEBI Listing Regulations.
Park Medi World ED Probe / Tax Survey
Park Medi World disclosed an Income Tax Department verification at some of its and its subsidiaries' premises. The company stated operations are unaffected.
Park Medi World Annual General Meeting
Park Medi World Limited held its 15th Annual General Meeting on September 22, 2026, where shareholders considered ordinary and special business items.
Other results update announcements
All →Mukka Proteins Results Update
Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.
- Oman facility manufacturing capacity
- 37200.0 MTPA
Aztec Fluids & Machinery Results Update
Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.
Ramky Infrastructure Results Update
Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.
Striders Impex Results Update
Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.
Jaro Institute of Technology Management and Research Results Update
Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.
Tata Chemicals Results Update
Tata Chemicals' Q2FY27 standalone revenue rose 8% to ₹1,303 Cr, with EBITDA up 22%. Consolidated results show a ₹50 Cr loss after tax amid soda ash pricing pressure.